Example: Heart Attack

Search clinical trials for: Pramlintide

Total 47 results

NCT01841359

Active, not recruiting

Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery

Conditions: Hypoglycemia, Evidence of Previous Gastric Surgery
NCT03560960

Recruiting

Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease

Conditions: Alzheimer Disease, Mild Cognitive Impairment
NCT04252612

Recruiting

Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study

Conditions: Cutaneous Squamous Cell Carcinoma
NCT04163874

Recruiting

Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas

Conditions: Type 1 Diabetes, Type 1 Diabetes Mellitus, Hyperglycemia, Postprandial
NCT04243629

Not yet recruiting

Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

Conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes, Postprandial Hyperglycemia
NCT03598075

Completed

Amylin and CGRP Head to Head Provocation in Migraine Without Aura Patients

Conditions: Migraine Without Aura
NCT04074317

Completed

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Conditions: Diabetes Mellitus, Type 1, Insulin-dependent Diabetes Mellitus
NCT00691158

Active, not recruiting

A Study of the Functional Magnetic Resonance Imaging Response to Leptin and Pramlintide

Conditions: Obesity
NCT03993366

Unknown status

Pramlintide and Fiasp Closed-Loop With a Simple Meal Announcement

Conditions: Type 1 Diabetes Mellitus
NCT03547427

Suspended

Glucagon Counterregulation in Type 1 Diabetes

Conditions: Type 1 Diabetes Mellitus
NCT00505882

Withdrawn

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

Conditions: Type 1 Diabetes
NCT00690235

Completed

Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia

Conditions: Schizophrenia, Schizoaffective Disorder, Diabetes, Weight Gain
NCT02500979

Completed

Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT01165944

Withdrawn

Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus

Conditions: Diabetes Mellitus
NCT00442767

Completed

Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT01269047

Completed

Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

Conditions: Type 1 Diabetes
NCT00950677

Completed

The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

Conditions: Type 2 Diabetes
NCT00291772

Completed

Continuous Subcutaneous Infusion of Pramlintide and Insulin

Conditions: Type 1 Diabetes
NCT00206297

Completed

The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes

Conditions: Type 1 Diabetes
NCT00206258

Completed

The Role of Amylin and Glucagon in T1DM

Conditions: Type 1 Diabetes
NCT00042601

Completed

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
NCT00042471

Completed

Evaluation of the Bioavailability of Pramlintide

Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
NCT00042458

Completed

Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

Conditions: Diabetes Mellitus, Type 1
NCT00107107

Completed

Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 1
NCT00842075

Completed

Pramlintide in Adolescents With Type 1 Diabetes

Conditions: Type 1 Diabetes